Pharmexcil Urges Chemical Allocation to Avert Drug Shortages Amid West Asia Conflict
Indian drug makers face a critical shortage of essential raw materials like propylene, methanol, ammonia, and butane due to the West Asia war. Pharmexcil has asked the government to divert supplies to prevent medicine shortages. Low inventories at solvent manufacturers threaten medicine availability. The government is considering implementing quotas to support the pharmaceutical sector and ensure a steady supply of crucial ingredients.
Indian pharmaceutical manufacturers are grappling with a critical shortage of essential raw materials, including propylene, methanol, ammonia, and butane. These chemicals are fundamental for producing solvents and active pharmaceutical ingredients, which are vital components in drug manufacturing. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has formally requested the government to intervene by diverting supplies of these key chemicals. This plea comes amid concerns that the ongoing West Asia conflict is impacting the availability and flow of these crucial inputs. The council has highlighted that solvent manufacturers, who are integral to the drug production chain, are operating with critically low inventory levels. This situation directly threatens the continuous production and availability of medicines, raising fears of potential widespread drug shortages across the country. In response to Pharmexcil's urgent appeal, the Indian government is actively exploring options, with the implementation of quotas being a primary consideration. These quotas would aim to prioritize and allocate the scarce chemical supplies to the pharmaceutical sector, thereby safeguarding the industry's ability to produce essential medicines and mitigate any potential health crisis stemming from a lack of drugs.
